GleamWall
中文EN

UTHR UNITED THERAPEUTICS Corp

Pharmaceutical Preparations · Nasdaq · SEC CIK 1082554 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY1.9%
TTM net income YoY-3.2%
TTM EPS YoY0.4%
Revenue 3-yr CAGR13.1%
Net income 3-yr CAGR11.0%

Margins

Gross margin86.3%
Operating margin41.4%
Net margin38.6%
FCF margin27.2%
EBITDA margin44.5%

Returns

ROE19.1%
ROA17.1%
ROIC (approx.)20.9%
Asset turnover0.44x

Leverage & solvency

Liabilities / assets10.8%
Debt / equity0.00x
Current ratio4.61x
Interest coverage111.02x

Cash quality & payout

Operating cash flow / net income1.16x
Accruals ratio-2.8%
Payout ratio—
Capex / revenue17.6%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$3.18B$2.88B
Cost of revenue$384.40M$309.70M
Gross profit$2.80B$2.57B
R&D expense$550.00M$481.00M
SG&A expense$755.80M$709.70M
Operating income$1.49B$1.38B
Interest expense$19.50M$42.90M
Pretax income$1.71B$1.54B
Income tax$379.20M$343.90M
Net income$1.33B$1.20B
EBITDA$1.58B$1.45B
EPS (basic)30.1326.44
EPS (diluted)27.8624.64
Weighted avg. shares (diluted)47.90M48.50M
Balance sheet
Cash & equivalents$1.56B$1.70B
Short-term investments$1.36B$1.57B
Receivables$350.20M$279.30M
Inventory$183.10M$157.90M
Current assets$3.70B$3.87B
PP&E, net$1.73B$1.22B
Goodwill$32.30M$32.30M
Total assets$7.88B$7.36B
Current liabilities$560.60M$738.10M
Total liabilities$783.80M$920.00M
Shareholders' equity$7.10B$6.44B
Shares outstanding43.64M44.83M
Cash flow statement
Operating cash flow$1.56B$1.33B
Capital expenditure$520.50M$246.50M
Free cash flow$1.04B$1.08B
Investing cash flow-$551.30M$417.20M
Financing cash flow-$1.15B-$1.25B
Depreciation & amortization$85.60M$72.50M
Stock-based compensation$147.70M$144.00M
Share buybacks$1.00B$1.00B

Free plan shows the latest 2 periods; Pro shows all 18 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.